Karen Le is an Endocrinology/Metabolic physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 7 publications with 312 citations (h-index 3); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9449 Imperial Hwy Ste 315
Downey, CA 902422814
Telephone
562-657-2375Provider last certified this registry record 8 Aug 2023.
Clinical trials
- Narrative Discourse Treatment Development
Sponsor: VA Office of Research and Development
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BETA BIONICS, INC.Program year20251 payment
- Abbott LaboratoriesProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
45.9%l-Thyroxine30.2%Levothyroxine Sodium100%Part D≥117 patientsThyroid Hormone Synthesis Inhibitor10%Methimazole100%Part D≥47 patients+ 2 more classes in this area
Cardiovascular
24.5%Statin9.5%Atorvastatin Calcium56%Rosuvastatin Calcium27%Pravastatin Sodium18%Part D<11 patientsAngiotensin receptor blocker (ARB)4.8%Losartan Potassium100%Part D≥25 patients+ 4 more classes in this area
Metabolism & gastrointestinal
20.3%Insulin Analog6%Insulin Glargine-Yfgn49%Humalog Kwikpen U-10028%Humalog24%Part D<11 patientsBiguanide (metformin)5.2%Metformin Hcl75%Metformin Hcl Er25%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Gnathodiaphyseal dysplasia: report of a family with a novel mutation of the ANO5 gene
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
2016 - Plasmapheresis-remediable Hyperinsulinemic Hypoglycemia in a Patient with Diabetes, Hypertriglyceridemia, and Cardiomyopathy
Journal of Clinical and Molecular Endocrinology
2016 - Hashimoto's Thyroiditis Does Not Predispose Patients to Differentiated Thyroid Cancer
Clinical Thyroidology
2014 - How long should we continue prednisone after abiraterone discontinuation?
PubMed
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Beth Karlan, MD
Cedars-Sinai Medical Center
Raj Makkar, MD
Cedars-Sinai Medical Center
Paul Noble, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”